Cargando…

COVID-19 in young and middle-aged adults: predictors of poor outcome and clinical differences

INTRODUCTION: Young and middle-aged adults are the largest group of patients infected with SARS-CoV-2 and some of them develop severe disease. OBJECTIVE: To investigate clinical manifestations in adults aged 18–65 years hospitalized for COVID-19 and identify predictors of poor outcome. Secondary obj...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tabernero, Eva, Ruiz, Luis A., España, Pedro P., Méndez, Raúl, Serrano, Leyre, Santos, Borja, Uranga, Ane, González, Paula, Garcia, Patricia, Torres, Antoni, Menendez, Rosario, Zalacain, Rafael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406039/ https://www.ncbi.nlm.nih.gov/pubmed/34463951 http://dx.doi.org/10.1007/s15010-021-01684-9

Ejemplares similares

Early Recognition of Low-Risk SARS-CoV-2 Pneumonia: A Model Validated With Initial Data and Infectious Diseases Society of America/American Thoracic Society Minor Criteria
por: Menéndez, Rosario, et al.
Publicado: (2022)

Bacteraemic pneumococcal pneumonia and SARS-CoV-2 pneumonia: differences and similarities
por: Serrano Fernández, Leyre, et al.
Publicado: (2022)

Impact of severe lymphopenia on the early prediction of clinical outcome in hospitalized patients with pneumococcal community-acquired pneumonia
por: Ruiz, Luis A., et al.
Publicado: (2023)

Early Initiation of Corticosteroids Might be Harmful in Patients Hospitalized With COVID-19 Pneumonia: A Multicenter Propensity Score Analysis
por: Pérez de Llano, Luis A., et al.
Publicado: (2022)

Predictors of Severe Sepsis among Patients Hospitalized for Community-Acquired Pneumonia
por: Montull, Beatriz, et al.
Publicado: (2016)

Bacteremic pneumococcal pneumonia: arrhythmogenic disease
por: Fernandez, Leyre Serrano, et al.
Publicado: (2022)

Predictors of mortality of COVID-19 in the general population and nursing homes
por: España, Pedro Pablo, et al.
Publicado: (2021)

Alteración funcional pulmonar en el seguimiento precoz de pacientes con neumonía por COVID-19
por: Tabernero Huguet, Eva, et al.
Publicado: (2021)

Impact of outdoor air pollution on severity and mortality in COVID-19 pneumonia
por: Bronte, O., et al.
Publicado: (2023)

Extracting relevant predictive variables for COVID-19 severity prognosis: An exhaustive comparison of feature selection techniques
por: Hayet-Otero, Miren, et al.
Publicado: (2023)

Diagnostic and therapeutic approach to occupational pneumonia
por: Yandiola, Pedro Pablo España, et al.
Publicado: (2022)

High‐flow nasal cannula oxygen therapy for the treatment of acute respiratory failure secondary to SARS‐CoV‐2 pneumonia out of ICU
por: Castro, Sonia, et al.
Publicado: (2023)

Importance of Aspergillus spp. isolation in Acute exacerbations of severe COPD: prevalence, factors and follow-up: the FUNGI-COPD study
por: Huerta, Arturo, et al.
Publicado: (2014)

The Evolution and Distribution of Pneumococcal Serotypes in Adults Hospitalized With Community-Acquired Pneumonia in Spain Using a Serotype-Specific Urinary Antigen Detection Test: The CAPA Study, 2011–2018
por: Torres, Antoni, et al.
Publicado: (2021)

Pneumococcal Serotypes Associated with Community-Acquired Pneumonia Hospitalizations in Adults in Spain, 2016–2020: The CAPA Study
por: Menéndez, Rosario, et al.
Publicado: (2023)

Lymphopenic community acquired pneumonia as signature of severe COVID-19 infection
por: Bermejo-Martin, Jesús F, et al.
Publicado: (2020)

Predicting 1-year mortality after hospitalization for community-acquired pneumonia
por: Uranga, Ane, et al.
Publicado: (2018)

Clinical Factors Associated with a Shorter or Longer Course of Antibiotic Treatment in Patients with Exacerbations of Bronchiectasis: A Prospective Cohort Study
por: Scioscia, Giulia, et al.
Publicado: (2019)

Age-related differences in management and outcomes in hospitalized healthy and well-functioning bacteremic pneumococcal pneumonia patients: a cohort study
por: Ruiz, Luis A., et al.
Publicado: (2017)

Immune treatment in COVID-19
por: Menéndez, Rosario, et al.
Publicado: (2022)

Reduced Diffusion Capacity in COVID-19 Survivors
por: Méndez, Raúl, et al.
Publicado: (2021)

Pneumococcal pneumonia: differences according to blood culture results
por: Capelastegui, Alberto, et al.
Publicado: (2014)

Changing epidemiology of nontuberculous mycobacterial lung disease over the last two decades in a region of the Basque country
por: Pedrero, Sandra, et al.
Publicado: (2019)

Compliance with Guidelines-Recommended Processes in Pneumonia: Impact of Health Status and Initial Signs
por: Menéndez, Rosario, et al.
Publicado: (2012)

Lymphopenic Community Acquired Pneumonia (L-CAP), an Immunological Phenotype Associated with Higher Risk of Mortality
por: Bermejo-Martin, Jesus F., et al.
Publicado: (2017)

Impact on in-hospital mortality of ceftaroline versus standard of care in community-acquired pneumonia: a propensity-matched analysis
por: Cilloniz, Catia, et al.
Publicado: (2021)

Impact of Prior SARS-CoV-2 Infection and Vaccination on COVID-19 Infection Among Nursing Home Residents
por: España, Pedro P., et al.
Publicado: (2023)

Impact of prior SARS-COV-2 infection and vaccination on COVID-19 hospital admission and mortality amongst nursing home residents
por: España, Pedro P., et al.
Publicado: (2023)

Utility of Differential White Cell Count and Cell Population Data for Ruling Out COVID-19 Infection in Patients With Community-Acquired Pneumonia
por: Uranga, Ane, et al.
Publicado: (2022)

Expert Consensus: Main Risk Factors for Poor Prognosis in COVID-19 and the Implications for Targeted Measures against SARS-CoV-2
por: Candel, Francisco Javier, et al.
Publicado: (2023)

Biomarkers in Community-Acquired Pneumonia (Cardiac and Non-Cardiac)
por: Méndez, Raúl, et al.
Publicado: (2020)

Correction to: Impact of reducing the duration of antibiotic treatment on the long-term prognosis of community acquired pneumonia
por: Uranga, Ane, et al.
Publicado: (2021)

Factors associated with hospitalization in bronchiectasis exacerbations: a one-year follow-up study
por: Menéndez, Rosario, et al.
Publicado: (2017)

Effect of Corticosteroids on C-Reactive Protein in Patients with Severe Community-Acquired Pneumonia and High Inflammatory Response: The Effect of Lymphopenia
por: Torres, Antoni, et al.
Publicado: (2019)

From starting mechanical ventilation to ventilator-associated pneumonia, choosing the right moment to start antibiotic treatment
por: Ramirez, Paula, et al.
Publicado: (2016)

Research in community-acquired pneumonia: the next steps
por: Torres, Antoni, et al.
Publicado: (2017)

Bacterial Pneumonia and Lung Abscess
por: Torres, Antoni, et al.
Publicado: (2016)

Systemic Inflammation during and after Bronchiectasis Exacerbations: Impact of Pseudomonas aeruginosa
por: Menéndez, Rosario, et al.
Publicado: (2020)

Risk factors for multidrug-resistant pathogens in bronchiectasis exacerbations
por: Menéndez, Rosario, et al.
Publicado: (2017)

Early life predictors of intelligence in young adulthood and middle age
por: Flensborg-Madsen, Trine, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hetc5lho3kku2vku1sph490lis